Helathy controls and patients with neurloglical disorder
Conditions
Interventions
Group 1: TThe aim is to record and map the walking patterns of the general population. This will be done across the 18–85 age range. This range can be divided into 6 groups, each covering a 10-year ag
Sponsors
Deutsches Zentrum für Neurodegenerative Erkrankungen
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Included are consenting adults of the general population general population with an ability of 2-10 meters and no gait impairment gait impairment (neurodegenerative disease such as ataxia, dementia ataxia, dementia, motor and cerebellar disorders, and sensory or motor neuropathies) are known and no gait aids are gait aids are required (e.g. walking aids such as crutches or a rollator).
Exclusion criteria
Exclusion criteria: Persons incapable of giving consent and persons with impaired gait or who are dependent on gait aids are excluded from the study. In addition, adult patients with neurological disorders who are capable of giving informed consent and are enrolled in ongoing studies at the participating study centers will be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantifiable standard values of a healthy gait. In comparison to the gait patern of patients with neurological disorders. A value results from the coordinates of a body marker in space either absolute or relative to other body markers. A body marker is a fixed position on the body, e.g. the left wrist. | — |
Secondary
| Measure | Time frame |
|---|---|
| In addition, the markers collected serve as a resource for future scientific questions. | — |
Countries
Germany
Contacts
Public ContactJennifer Faber
Deutsches Zentrum für Neurodegenerative Erkrankungen
Outcome results
None listed